Sayed Himmat

Sayed Himmat

Auto-generated profile, based on publicly available information

Sayed Himmat

Departments of Surgery, University of Alberta, Edmonton, Alberta, Canada; Alberta Transplant Institute, Edmonton, Alberta, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
NANader S. Aboelnazar
Nader S. Aboelnazar
SHSayed Himmat
Sayed Himmat
SHSanaz Hatami
Sanaz Hatami
CWChristopher W. White
Christopher W. White
MBMohamad S. Burhani
Mohamad S. Burhani
JNJayan Nagendran
Jayan Nagendran

16 August 2019 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MBMax T. Buchko
Max T. Buchko
CSCatherine J. Stewart
Catherine J. Stewart
SHSanaz Hatami
Sanaz Hatami
SHSayed Himmat
Sayed Himmat
DFDarren H. Freed
Darren H. Freed
JNJayan Nagendran
Jayan Nagendran
Ex vivo lung perfusion (EVLP) protocols generally limit metabolic supplementation to insulin and glucose. We sought to determine whether the addition of total parenteral nutrition (TPN) would improve lung function in EVLP. Ten porcine lungs were perfused using EVLP for 24 hours and supplemented with insulin and glucose. In the treatment group (n = 5), the perfusate was also supplemented with a continuous infusion of TPN containing lipids, amino acids, essential vitamins, and cofactors. Physiologic parameters and perfusate electrolytes were continuously evaluated. Perfusate lactate, lipid and branch chain amino acid (BCAA) concentrations were also analyzed to elucidate how substrates were being utilized over time. Lungs in the TPN group exhibited significantly better oxygenation. Perfusate sodium was more stable in the TPN group. In the control group, free fatty acids (FFA) were quickly depleted, reaching negligible levels early in the perfusion. Alternatively, BCAA in the control group rose continually over the perfusion demonstrating a shift toward proteolysis for energy substrate. In the TPN group, both FFA and BCAA concentrations remained stable at in vivo levels after initial stabilization. TNF-α concentrations were lower in the TPN group. The addition of TPN in EVLP allows for better electrolyte composition, decreased inflammation, and improved graft performance.

1 September 2017 in ASAIO Journal
Verified
Journal Article
Closed access
JLJessica G. Y. Luc
Jessica G. Y. Luc
NANader S. Aboelnazar
Nader S. Aboelnazar
SHSayed Himmat
Sayed Himmat
SHSanaz Hatami
Sanaz Hatami
AHAlois Haromy
Alois Haromy
JNJayan Nagendran
Jayan Nagendran
Normothermic ex vivo lung perfusion (EVLP) allows for assessment and reconditioning of donor lungs. Although a leukocyte filter (LF) is routinely incorporated into the EVLP circuit; its efficacy remains to be determined. Twelve pig lungs were perfused and ventilated ex vivo in a normothermic state for 12 hours. Lungs (n = 3) were allocated to four groups according to perfusate composition and the presence or absence of a LF in the circuit (acellular ± LF, cellular ± LF). Acceptable physiologic lung parameters were achieved during EVLP; however, increased amounts of pro-inflammatory cytokines (TNF-α and IL-6) and leukocytes in the perfusate were observed despite the presence or absence of a LF. Analysis of cells washed off the LF demonstrates that it trapped leukocytes although being ineffective throughout perfusion as it became saturated over 12 hours of EVLP. We conclude that there is no objective evidence to support the routine incorporation of a LF during EVLP as it does not provide further benefit and its removal does not appear to cause harm. The lack of hypothesized benefit to a LF may be because of the saturation of the LF with donor leukocytes, leading to similar amounts of circulating leukocytes still present in the perfusate with and without a LF.

19 August 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
XQXiao Qi
Xiao Qi
SHSanaz Hatami
Sanaz Hatami
SBSabin Bozso
Sabin Bozso
MBMax Buchko
Max Buchko
KFKeir A. Forgie
Keir A. Forgie
DFDarren H. Freed
Darren H. Freed
Evidence suggests that hearts that are perfused under ex-situ conditions lose normal coronary vasomotor tone and experience contractile failure over a few hours. We aimed to evaluate the effect of different coronary perfusion strategies during ex situ heart perfusion on cardiac function and coronary vascular tone. Porcine hearts (n = 6 each group) were perfused in working mode for 6 hours with either constant aortic diastolic pressure (40 mmHg) or constant coronary flow rate (500 mL/min). Functional and metabolic parameters, cytokine profiles, cardiac and vascular injury, coronary artery function and oxidative stress were compared between groups. Constant coronary flow perfusion demonstrated better functional preservation and less edema formation (Cardiac index: flow control = 8.33 vs pressure control = 6.46 mL·min-1·g-1, p = 0.016; edema formation: 7.92% vs 19.80%, p < 0.0001). Pro-inflammatory cytokines, platelet activation as well as endothelial activation were lower in the flow control group. Similarly, less cardiac and endothelial injury was observed in the constant coronary flow group. Evaluation of coronary artery function showed there was loss of coronary autoregulation in both groups. Oxidative stress was induced in the coronary arteries and was relatively lower in the flow control group. A strategy of controlled coronary flow during ex situ heart perfusion provides superior functional preservation and less edema formation, together with less myocardial damage, leukocyte, platelet, endothelial activation, and oxidative stress. There was loss of coronary autoregulation and decrease of coronary vascular resistance during ESHP irrespective of coronary flow control strategy. Inflammation and oxidative stress state in the coronary vasculature may play a role.

20 December 2017 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
SHSayed Himmat
Sayed Himmat
AAAlmothana Alzamil
Almothana Alzamil
NANader Aboelnazar
Nader Aboelnazar
SHSanaz Hatami
Sanaz Hatami
CWChristopher White
Christopher White
JNJayan Nagendran
Jayan Nagendran

17 January 2025 in Clinical Transplantation
Verified
Journal Article
Closed access
KFKeir Forgie
Keir Forgie
SHSayed Himmat
Sayed Himmat
KDKatie Du
Katie Du
ARAlynne Ribano
Alynne Ribano
AWAbeline Watkins
Abeline Watkins
JNJayan Nagendran
Jayan Nagendran